KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Change in Taxes (2016 - 2019)

Arbutus Biopharma (ABUS) has disclosed Change in Taxes for 6 consecutive years, with -$98000.0 as the latest value for Q1 2019.

  • Quarterly Change in Taxes fell 5000.0% to -$98000.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was -$49000.0 through Mar 2019, up 80.0% year-over-year, with the annual reading at $49000.0 for FY2018, 4.26% up from the prior year.
  • Change in Taxes hit -$98000.0 in Q1 2019 for Arbutus Biopharma, down from $49000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $108000.0 in Q3 2017 to a low of -$294000.0 in Q2 2017.
  • Historically, Change in Taxes has averaged -$23000.0 across 5 years, with a median of $15000.0 in 2017.
  • Biggest five-year swings in Change in Taxes: soared 180.33% in 2018 and later tumbled 5000.0% in 2019.
  • Year by year, Change in Taxes stood at $25000.0 in 2015, then soared by 88.0% to $47000.0 in 2016, then tumbled by 229.79% to -$61000.0 in 2017, then skyrocketed by 180.33% to $49000.0 in 2018, then tumbled by 300.0% to -$98000.0 in 2019.
  • Business Quant data shows Change in Taxes for ABUS at -$98000.0 in Q1 2019, $49000.0 in Q4 2018, and $2000.0 in Q1 2018.